These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 23378621)

  • 21. HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry Findings.
    Miller KM; Beck RW; Foster NC; Maahs DM
    Diabetes Technol Ther; 2020 Sep; 22(9):645-650. PubMed ID: 31905008
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 Diabetes Self-Management From Emerging Adulthood Through Older Adulthood.
    McCarthy MM; Grey M
    Diabetes Care; 2018 Aug; 41(8):1608-1614. PubMed ID: 29802144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with type 1 diabetes mellitus.
    Patton SR; Clements MA; Fridlington A; Cohoon C; Turpin AL; Delurgio SA
    Diabetes Technol Ther; 2013 Feb; 15(2):124-8. PubMed ID: 23317372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.
    Redondo MJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Wood JR; Buckingham B; Klingensmith GJ; Silverstein J; Tamborlane WV;
    Pediatr Diabetes; 2014 Jun; 15(4):294-302. PubMed ID: 23889707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes.
    Maahs DM; Chase HP; Westfall E; Slover R; Huang S; Shin JJ; Kaufman FR; Pyle L; Snell-Bergeon JK
    Diabetes Technol Ther; 2014 May; 16(5):284-91. PubMed ID: 24450776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in A1c Levels in Early Adulthood in the T1D Exchange: Impact of Racial, Socioeconomic, and Clinical Factors.
    Toschi E; Bailey RJ; Miller KM; Calhoun PM
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1294-1302. PubMed ID: 33567069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
    Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
    Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
    Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
    Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Transatlantic HbA
    Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
    Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.
    Kusunoki Y; Katsuno T; Nakae R; Watanabe K; Akagami T; Ochi F; Tokuda M; Murai K; Miuchi M; Miyagawa J; Namba M
    Diabetes Res Clin Pract; 2015 May; 108(2):342-9. PubMed ID: 25779865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus.
    Deeb A; Abu-Awad S; Abood S; El-Abiary M; Al-Jubeh J; Yousef H; AbdelRahman L; Al Hajeri A; Mustafa H
    Diabetes Technol Ther; 2015 Mar; 17(3):166-70. PubMed ID: 25513744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance.
    Addala A; Maahs DM; Scheinker D; Chertow S; Leverenz B; Prahalad P
    Pediatr Diabetes; 2020 Nov; 21(7):1301-1309. PubMed ID: 32681582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
    Sherr J; Tamborlane WV; Xing D; Tsalikian E; Mauras N; Buckingham B; White NH; Arbelaez AM; Beck RW; Kollman C; Ruedy K;
    Diabetes Care; 2012 Apr; 35(4):817-20. PubMed ID: 22323414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C.
    Skeie S; Kristensen GB; Carlsen S; Sandberg S
    J Diabetes Sci Technol; 2009 Jan; 3(1):83-8. PubMed ID: 20046652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.